Xiang Hua Cheng
Corporate Officer/Principal bei SIMCERE PHARMACEUTICAL GROUP LIMITED
Profil
Xiang Hua Cheng is currently the Chairman of Oy Simcere Europe Ltd., Director of Simcere Pharmaceutical (Hainan) Co. Ltd., Director of Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., Director of Wuhu Simcere Zhongren Pharmaceutical Co. Ltd., Director of Shanghai Simcere Pharmaceutical Co. Ltd., and Director of Xuancheng Menovo Pharmaceutical Co., Ltd.
He is also the Vice President of Simcere Pharmaceutical Group Ltd.
Mr. Cheng obtained his undergraduate degree from Anhui University of Chinese Medicine in 1999.
Aktive Positionen von Xiang Hua Cheng
Unternehmen | Position | Beginn |
---|---|---|
SIMCERE PHARMACEUTICAL GROUP LIMITED | Corporate Officer/Principal | 01.06.2000 |
Oy Simcere Europe Ltd. | Vorsitzender | 01.06.2019 |
Wuhu Simcere Zhongren Pharmaceutical Co. Ltd. | Direktor/Vorstandsmitglied | 01.07.2017 |
Shanghai Simcere Pharmaceutical Co. Ltd. | Direktor/Vorstandsmitglied | 01.01.2017 |
Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd. | Direktor-Back Office Betrieb | 01.04.2020 |
Simcere Pharmaceutical (Hainan) Co. Ltd.
Simcere Pharmaceutical (Hainan) Co. Ltd. Pharmaceuticals: OtherHealth Technology Hainan Simcere Pharmaceutical Co., Ltd. is a generic phamaceutical manufacturing company. It offers products involving treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea & vomiting associated with chemotherapy. The company was founded in April 1993 and is headquartered in Hainan, CN. | Direktor/Vorstandsmitglied | 01.05.2020 |
Xuancheng Menovo Pharmaceutical Co. , Ltd.
Xuancheng Menovo Pharmaceutical Co. , Ltd. Pharmaceuticals: MajorHealth Technology Part of Ningbo Menovo Pharmaceutical Co., Ltd., Xuancheng Menovo Pharmaceutical Co., Ltd. is a company that manufactures and wholesales pharmaceutical intermediates, ingredients, and medicines. The company is based in Ningbo, China. Xuancheng Menovo Pharmaceutical Co. was acquired by Ningbo Menovo Pharmaceutical Co., Ltd. on July 01, 2022 for $23.14 million. The Chinese company was founded in 2004. | Direktor/Vorstandsmitglied | 01.07.2019 |
Ausbildung von Xiang Hua Cheng
Anhui University of Chinese Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
Private Unternehmen | 6 |
---|---|
Simcere Pharmaceutical (Hainan) Co. Ltd.
Simcere Pharmaceutical (Hainan) Co. Ltd. Pharmaceuticals: OtherHealth Technology Hainan Simcere Pharmaceutical Co., Ltd. is a generic phamaceutical manufacturing company. It offers products involving treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea & vomiting associated with chemotherapy. The company was founded in April 1993 and is headquartered in Hainan, CN. | Health Technology |
Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd. | |
Oy Simcere Europe Ltd. | |
Wuhu Simcere Zhongren Pharmaceutical Co. Ltd. | |
Shanghai Simcere Pharmaceutical Co. Ltd. | |
Xuancheng Menovo Pharmaceutical Co. , Ltd.
Xuancheng Menovo Pharmaceutical Co. , Ltd. Pharmaceuticals: MajorHealth Technology Part of Ningbo Menovo Pharmaceutical Co., Ltd., Xuancheng Menovo Pharmaceutical Co., Ltd. is a company that manufactures and wholesales pharmaceutical intermediates, ingredients, and medicines. The company is based in Ningbo, China. Xuancheng Menovo Pharmaceutical Co. was acquired by Ningbo Menovo Pharmaceutical Co., Ltd. on July 01, 2022 for $23.14 million. The Chinese company was founded in 2004. | Health Technology |